Every Form 4 that Chimera Investment Corporation 9.000% Senior Notes due 2029 (CIMN) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow CIMN and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CIMN filings page.
Mills Susan reported acquisition or exercise transactions in this Form 4 filing.
Chimera Investment Corp director Susan Mills reported an award of 11,263 restricted stock units (RSUs) tied to Chimera common stock. Each RSU is economically equivalent to one share of common stock and is scheduled to vest on the earlier of June 11, 2027 or the next annual stockholders meeting. The award will be settled entirely in shares of Chimera common stock. Following this grant, Mills reports beneficial ownership of 37,757 shares, including the RSUs.
STILL DEBRA reported acquisition or exercise transactions in this Form 4 filing.
Chimera Investment Corp director Debra Still received a grant of 11,263 restricted stock units (RSUs) of common stock as compensation. The award was recorded at a price of $0.00 per share, indicating a non-cash equity grant rather than an open-market purchase.
The RSUs are scheduled to vest on the earlier of the first anniversary of the grant date on June 11, 2027, or the date of Chimera’s next annual stockholders meeting, and will be settled entirely in shares of Chimera common stock. After this grant, Still directly holds 60,706 shares of Chimera common stock. Each RSU has the economic equivalent of one share of Chimera common stock.
Chavers Kevin Gerald reported acquisition or exercise transactions in this Form 4 filing.
Chimera Investment Corp director Kevin Gerald Chavers reported an equity award of 11,263 restricted stock units (RSUs) tied to Chimera common stock. The RSUs, each economically equal to one share, were granted at no cash cost and will vest on the earlier of the first anniversary of the June 11, 2026 grant date or the next annual stockholders meeting, then be settled entirely in shares. After this grant, Chavers holds 50,506 shares of Chimera common stock.
Walsh Cynthia B reported acquisition or exercise transactions in this Form 4 filing.
Chimera Investment Corp director Cynthia B. Walsh received an equity award of 11,263 shares of common stock in the form of restricted stock units (RSUs). The grant was made at a stated price of $0.00 per share as a compensation award, not an open-market purchase.
The RSUs are scheduled to vest on the earlier of the first anniversary of the grant date, June 11, 2027, or the date of Chimera’s next annual stockholders meeting, and will be settled entirely in Chimera common stock on vesting. Following this grant, Walsh directly holds 26,765 shares of Chimera common stock, including the unvested RSUs. Each RSU has the economic equivalent of one share of Chimera common stock.
Reilly Brian Patrick reported acquisition or exercise transactions in this Form 4 filing.
Chimera Investment Corp director Brian Patrick Reilly received an equity grant of 11,263 restricted stock units (RSUs) of common stock. The RSUs vest on the earlier of the first anniversary of the June 11, 2026 grant date or the next annual stockholders meeting and will be settled entirely in Chimera common shares. After this award, Reilly holds 106,133 shares of common stock, reflecting a compensation-related grant rather than an open-market purchase.
CREAGH GERARD reported acquisition or exercise transactions in this Form 4 filing.
Chimera Investment Corp director Gerard Creagh received an equity award of 11,263 restricted stock units (RSUs) on Chimera common stock. The RSUs are scheduled to vest on the earlier of the first anniversary of the grant date on June 11, 2027, or the date of Chimera’s next annual stockholders meeting, and will be settled entirely in shares of common stock. After this grant, Creagh directly holds 188,015 shares of Chimera common stock. This is a compensation-related grant rather than an open‑market purchase.
Chimera Investment Corp Chief Legal Officer and Secretary Miyun Sung reported a tax-related share disposition. On February 17, 2026, 8,165 shares of common stock were withheld at $13.70 per share to cover taxes tied to previously vested restricted stock units.
After this tax-withholding disposition, Sung directly holds 60,836 shares of Chimera common stock. Footnotes explain that dividend equivalent rights linked to restricted and performance stock units are included in this common stock balance and are economically equivalent to one share each.
Chimera Investment Corp's Chief Investment Officer, Jack Lee Macdowell Jr., reported a Form 4 transaction involving a tax-related share disposition. A total of 12,200 shares of common stock were withheld at a price of $13.70 per share to cover taxes tied to previously granted restricted stock units that vested.
After this tax-withholding disposition, Macdowell directly holds 302,421 shares of Chimera common stock. Footnotes clarify that dividend equivalent rights on RSUs and performance stock units are included in his reported common stock balance, with each right economically equivalent to one share.
Chimera Investment Corp’s Chief Financial Officer, Viswanathan Subramaniam, reported a tax-related share disposition. On February 17, 2026, he disposed of 51,800 shares of common stock at $13.70 per share through a transaction classified as a tax-withholding disposition.
According to the footnotes, these shares were withheld to pay taxes tied to the vesting of earlier performance stock unit (PSU) and restricted stock unit (RSU) awards. After this withholding, his directly held common stock balance was 200,507 shares. The filing also notes that dividend equivalent rights on RSUs and PSUs are included in this common stock balance.
Chimera Investment Corp president and CEO Phillip John Kardis II reported a tax-related share disposition tied to equity awards. On February 17, 2026, 127,168 shares of common stock were withheld at $13.70 per share to cover taxes on vesting performance and restricted stock units.
After this withholding, his directly held common stock balance is 579,085 shares. Footnotes explain that dividend equivalent rights on these units are included in his common stock holdings, and that each right is economically equivalent to one share of Chimera common stock.
Chimera Investment Corp’s Chief Investment Officer Jack Lee Macdowell Jr reported an award of 85,701 shares of common stock on January 20, 2026. These shares represent restricted stock units (RSUs), with each RSU economically equivalent to one share of Chimera common stock and scheduled to vest in three equal installments on December 31 of 2026, 2027, and 2028, and to be settled entirely in shares.
Following this grant, Macdowell beneficially owns 312,791 shares of Chimera common stock, which includes dividend equivalent rights issued on RSUs. The transaction price is reported as $0 per share, reflecting that this is an equity compensation award rather than an open-market purchase.
Chimera Investment Corporation’s Chief Financial Officer, Viswanathan Subramaniam, reported an equity award tied to the company’s common stock. On January 20, 2026 he was granted 54,537 restricted stock units (RSUs), each economically equivalent to one share of Chimera common stock and reported at a transaction price of $0, reflecting the nature of the award rather than a market purchase.
The RSUs are scheduled to vest in three equal installments on December 31 of 2026, 2027 and 2028, and will be settled entirely in Chimera common shares. Following this grant, the reporting person beneficially owned 247,826 shares of Chimera common stock on a direct basis, a figure that also includes dividend equivalent rights, which are treated as the economic equivalent of additional shares.
Chimera Investment Corp’s Chief Legal Officer and Secretary, Miyun Sung, reported receiving 31,164 shares of common stock on January 20, 2026, at a price of $0 per share. These shares represent common stock underlying restricted stock units that are scheduled to vest in three equal installments on December 31 of 2026, 2027, and 2028 and will be settled entirely in Chimera common stock.
After this grant, Sung beneficially owns 67,958 shares of Chimera common stock in direct form, with this balance including dividend equivalent rights on the RSUs, each of which is the economic equivalent of one share.
Chimera Investment Corporation’s President and CEO, Phillip John Kardis II, reported an equity award of 194,774 shares of common stock on January 20, 2026. These shares represent restricted stock units (RSUs), each economically equal to one share of Chimera common stock, granted at a price of $0 per share as part of compensation.
The RSUs are scheduled to vest in three equal installments on December 31, 2026, 2027 and 2028, and will be settled entirely in Chimera common stock. Following this grant, Kardis beneficially owns 695,495 shares of Chimera common stock directly, which also include dividend equivalent rights tied to prior RSUs and performance stock units.
Chimera Investment Corporation reported an insider equity transaction by President, CEO, and Director Phillip John Kardis II. On 12/18/2025, he acquired 101,772 shares of Chimera common stock at a stated price of $0, reflecting the vesting of performance stock units and associated dividend equivalent rights. Each performance stock unit and each dividend equivalent right is the economic equivalent of one share of Chimera common stock.
Following this vesting event, Kardis beneficially owns 500,721 shares of Chimera common stock in direct form.
Chimera Investment Corporation’s chief financial officer Subramaniam Viswanathan reported a stock-based compensation event. On 12/18/2025, he acquired 47,251 shares of Chimera common stock at a price of $0, reflecting the vesting of performance stock units and related dividend equivalent rights. Following this transaction, he beneficially owned 193,289 shares of common stock in total, held directly.
The filing explains that each performance stock unit and each dividend equivalent right is economically equivalent to one share of Chimera common stock, and dividend equivalent rights on restricted stock units and performance stock units are included in his common stock balance. This is a routine Form 4 disclosure of equity awards rather than an open-market purchase.
Chimera Investment Corp. reported an insider equity transaction by its Chief Legal Officer & Secretary, Miyun Sung. On 12/01/2025, 2,586 shares of Chimera common stock were withheld at a price of $12.79 per share to cover taxes related to the settlement of deferred shares from previously granted performance stock units (PSUs) and restricted stock units (RSUs). These settlements are tied to the liquidation of Chimera’s Stock Award Deferral Program on November 30, 2025, which had been described in the company’s prior annual report. After this tax-withholding transaction, Sung beneficially owned 36,794 shares of Chimera common stock, including dividend equivalent rights that are economically equal to additional shares.
Chimera Investment Corp’s Chief Financial Officer, Subramaniam Viswanathan, reported an automatic share withholding related to equity compensation. On 12/01/2025, 31,675 shares of Chimera common stock were withheld at a price of $12.79 per share to cover taxes due on the settlement of previously granted performance stock units (PSUs) and restricted stock units (RSUs). These units vested in connection with the liquidation of Chimera’s Stock Award Deferral Program on November 30, 2025. Following this tax withholding, the CFO beneficially owns 145,931 shares of Chimera common stock, which include dividend equivalent rights that are each economically equivalent to one share.
Chimera Investment Corp's President and CEO, who is also a director, reported a Form 4 insider transaction dated 12/01/2025. The filing shows that 102,926 shares of common stock were withheld as payment of taxes tied to the settlement of deferred Chimera shares, following the vesting of prior performance stock units (PSUs) and restricted stock units (RSUs) under the company’s Stock Award Deferral Program, which was liquidated on November 30, 2025. After this tax withholding, the reporting person beneficially owns 394,169 shares of Chimera common stock, which include dividend equivalent rights (DERs), with each DER economically equal to one share.